Page last updated: 2024-11-06

1-palmitoyl-lysophosphatidic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-palmitoyl-LPA is a bioactive lysophospholipid that acts as a signaling molecule in various cellular processes. It is produced by the enzymatic hydrolysis of phosphatidic acid (PA) by phospholipases A1 or A2. 1-palmitoyl-LPA has been shown to exert diverse biological effects, including cell proliferation, migration, differentiation, and survival. It is known to activate G protein-coupled receptors (GPCRs), specifically the LPA receptors (LPARs), which belong to the endothelial differentiation gene (EDG) family. The interaction of 1-palmitoyl-LPA with LPARs triggers downstream signaling pathways that regulate cell behavior. 1-palmitoyl-LPA is implicated in various physiological and pathological processes, including wound healing, inflammation, cancer development, and cardiovascular disease. Its role in these processes has made it a subject of intensive research, aiming to understand its mechanisms of action and potential therapeutic applications. '

1-palmitoyl-lysophosphatidic acid: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-palmitoylglycerol 3-phosphate : A monoacylglycerol phosphate having palmitoyl as the acyl group on O-1 and with the phosphate group on O-3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID89566
CHEMBL ID1206059
CHEBI ID64023
SCHEMBL ID2718543
MeSH IDM0087366

Synonyms (30)

Synonym
1-palmitoylglycerol 3-phosphate
C04036
lpa 16:0
22002-85-3
1-palmitoyl lysophosphatidic acid
(2-hydroxy-3-phosphonooxypropyl) hexadecanoate
CHEMBL1206059
hexadecanoic acid, 2-hydroxy-3-(phosphonooxy)propyl ester
einecs 244-707-4
1-palmitoyl-lysophosphatidic acid
2-hydroxy-3-(phosphonooxy)propyl palmitate
hexadecanoic acid,2-hydroxy-3-(phosphonooxy)propyl ester
CHEBI:64023 ,
SCHEMBL2718543
2-hydroxy-3-(phosphonooxy)propyl ester hexadecanoic acid
LMGP10050041
1-hexadecanoyl-phosphatidic acid
2-hydroxy-3-(phosphonooxy)propyl ester hexadecanoate
1-palmitoyl-glycero-3-phosphate
1-palmitoyllysophosphatidate
1-palmitoyl lysophosphatidate
1-palmitoyllysophosphatidic acid
2-hydroxy-3-(phosphonooxy)propyl hexadecanoate
DTXSID10865026
Q27132973
PD048956
AKOS040755730
HY-126967
CS-0108966
EX-A8005E
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
2-lysophosphatidic acidAny member of the class of lysophosphatidic acids which has a free hydroxy group at the 2-position of the glycerol moiety.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's5 (38.46)18.2507
2000's0 (0.00)29.6817
2010's1 (7.69)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.00 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]